Redeye analyst Richard Remanius recently interviewed CEO Sofia Heigis about Q4 and the upcoming new share issue of approximately SEK 200 million. The interview is held in Swedish.
Watch the interview via this link (requires free membership at Redeye).
Learn more about the company Oncopeptides and the work we do to redefine cancer care
Learn more about the company Oncopeptides and the work we do to redefine cancer care
Learn more about the company Oncopeptides and the work we do to redefine cancer care
Learn more about the company Oncopeptides and the work we do to redefine cancer care
